Canton Hathaway’s Opko Health OPK Stock Holding History

Canton Hathaway’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,900	Closed	-$41K	–	294
2020 Q2	$41K	Buy	+11,900	New	+$26.7K	0.03%	110

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Canton Hathaway's OPK Position: Q3 2020 in Review

Canton Hathaway sold out of Opko Health (OPK) in Q3 2020, closing a stake of 11,900 shares — an estimated $41K sold.

Canton Hathaway first reported a position in OPK in Q2 2020 and held it in 1 quarter. The position peaked at $41K in Q2 2020. 212 funds tracked by Wall St. Rank hold OPK as of Q3 2020.

Canton Hathaway reported no remaining Opko Health position as of Q3 2020 after selling out during the quarter.
Canton Hathaway sold 11,900 Opko Health shares in Q3 2020, an estimated $41K.
Canton Hathaway first reported a position in Opko Health in Q2 2020 and held it in 1 quarter.
Canton Hathaway's Opko Health position peaked at $41K in Q2 2020.
212 funds tracked by Wall St. Rank held Opko Health as of Q3 2020.

Based on Canton Hathaway's 13F filing for Q3 2020, filed 9 Nov 2020.